These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3474668)

  • 1. Genetically engineered drugs: toxicology with a difference.
    Finkle BS
    Prog Clin Biol Res; 1987; 235():161-7. PubMed ID: 3474668
    [No Abstract]   [Full Text] [Related]  

  • 2. The preclinical development of biotechnology-derived pharmaceuticals: the PMA perspective. Pharmaceutical Manufacturers Association.
    Stoll RE
    Prog Clin Biol Res; 1987; 235():169-71. PubMed ID: 3474669
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon alpha/beta.
    Gresser I; Woodrow D; Moss J; Maury C; Tavernier J; Fiers W
    Am J Pathol; 1987 Jul; 128(1):13-8. PubMed ID: 3605310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.
    Lawrence D; Shahrokh Z; Marsters S; Achilles K; Shih D; Mounho B; Hillan K; Totpal K; DeForge L; Schow P; Hooley J; Sherwood S; Pai R; Leung S; Khan L; Gliniak B; Bussiere J; Smith CA; Strom SS; Kelley S; Fox JA; Thomas D; Ashkenazi A
    Nat Med; 2001 Apr; 7(4):383-5. PubMed ID: 11283636
    [No Abstract]   [Full Text] [Related]  

  • 5. Planned introductions of engineered organisms: wisdom from the U.S. National Academy of Sciences.
    Miller HI; Young FE
    Bioessays; 1988 Apr; 8(4):99-100. PubMed ID: 3163918
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell cycle-specific effects of tumor necrosis factor.
    Darzynkiewicz Z; Williamson B; Carswell EA; Old LJ
    Cancer Res; 1984 Jan; 44(1):83-90. PubMed ID: 6690064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some aspects of the preclinical safety of drugs produced by recombinant DNA technology: Japanese government regulatory position.
    Hayakawa T
    Prog Clin Biol Res; 1987; 235():15-29. PubMed ID: 3299390
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.
    Taverne J; Tavernier J; Fiers W; Playfair JH
    Clin Exp Immunol; 1987 Jan; 67(1):1-4. PubMed ID: 3621669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K; Barth RF; Wilkie N; Lang JC; Oda Y; Kikuchi H; Everson MP; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):113-24. PubMed ID: 7621259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research.
    Bolon B
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):154-61. PubMed ID: 15504150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited effects of recombinant human and murine interleukin 1 and tumour necrosis factor on production of acute phase proteins by cultured rat hepatocytes.
    Koj A; Kurdowska A; Magielska-Zero D; Rokita H; Sipe JD; Dayer JM; Demczuk S; Gauldie J
    Biochem Int; 1987 Mar; 14(3):553-60. PubMed ID: 3496098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin.
    Sora MK; Kruszewski AA; Stokłosa T; Czyzyk J; Lasek W; Malejczyk J; Jakóbisiak M
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):269-74. PubMed ID: 7487365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
    Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
    J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activity of recombinant human tumor necrosis factor (TNF)].
    Somura K; Nakano K; Abe M; Nakata K; Yoshida H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):160-2. PubMed ID: 3966807
    [No Abstract]   [Full Text] [Related]  

  • 16. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins.
    Weikert S; Papac D; Briggs J; Cowfer D; Tom S; Gawlitzek M; Lofgren J; Mehta S; Chisholm V; Modi N; Eppler S; Carroll K; Chamow S; Peers D; Berman P; Krummen L
    Nat Biotechnol; 1999 Nov; 17(11):1116-21. PubMed ID: 10545921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical safety evaluation of recombinant human interleukin-10.
    Rosenblum IY; Johnson RC; Schmahai TJ
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):56-71. PubMed ID: 11846636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
    Abe Y; Yoshikawa T; Kamada H; Shibata H; Nomura T; Minowa K; Kayamuro H; Katayama K; Miyoshi H; Mukai Y; Yoshioka Y; Nakagawa S; Tsunoda S; Tsutsumi Y
    J Immunol Methods; 2008 Jun; 335(1-2):71-8. PubMed ID: 18417150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.
    Hansen K; Khanna C
    Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.
    De Titto EH; Catterall JR; Remington JS
    J Immunol; 1986 Aug; 137(4):1342-5. PubMed ID: 3525677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.